These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 15034931

  • 1. Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts.
    Yaroslavskiy BB, Li Y, Ferguson DJ, Kalla SE, Oakley JI, Blair HC.
    J Cell Biochem; 2004 Apr 01; 91(5):962-72. PubMed ID: 15034931
    [Abstract] [Full Text] [Related]

  • 2. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC, Borysenko CW, Villa A, Schlesinger PH, Kalla SE, Yaroslavskiy BB, Garćia-Palacios V, Oakley JI, Orchard PJ.
    J Bone Miner Res; 2004 Aug 01; 19(8):1329-38. PubMed ID: 15231021
    [Abstract] [Full Text] [Related]

  • 3. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H, Härkönen PL, Väänänen HK, Hentunen TA.
    J Bone Miner Res; 2005 Dec 01; 20(12):2224-32. PubMed ID: 16294275
    [Abstract] [Full Text] [Related]

  • 4. Low NO concentrations inhibit osteoclast formation in mouse marrow cultures by cGMP-dependent mechanism.
    Holliday LS, Dean AD, Lin RH, Greenwald JE, Gluck SL.
    Am J Physiol; 1997 Mar 01; 272(3 Pt 2):F283-91. PubMed ID: 9087669
    [Abstract] [Full Text] [Related]

  • 5. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
    Kudo O, Sabokbar A, Pocock A, Itonaga I, Athanasou NA.
    Calcif Tissue Int; 2002 Dec 01; 71(6):539-46. PubMed ID: 12232680
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor.
    Nicholls BM, Bredius RG, Hamdy NA, Gerritsen EJ, Lankester AC, Hogendoorn PC, Nesbitt SA, Horton MA, Flanagan AM.
    J Bone Miner Res; 2005 Dec 01; 20(12):2264-70. PubMed ID: 16294279
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties.
    Chu K, Snyder R, Econs MJ.
    J Bone Miner Res; 2006 Jul 01; 21(7):1089-97. PubMed ID: 16813529
    [Abstract] [Full Text] [Related]

  • 10. M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase.
    Glantschnig H, Fisher JE, Wesolowski G, Rodan GA, Reszka AA.
    Cell Death Differ; 2003 Oct 01; 10(10):1165-77. PubMed ID: 14502240
    [Abstract] [Full Text] [Related]

  • 11. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
    Kindle L, Rothe L, Kriss M, Osdoby P, Collin-Osdoby P.
    J Bone Miner Res; 2006 Feb 01; 21(2):193-206. PubMed ID: 16418775
    [Abstract] [Full Text] [Related]

  • 12. Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
    Zhao H, Kitaura H, Sands MS, Ross FP, Teitelbaum SL, Novack DV.
    J Bone Miner Res; 2005 Dec 01; 20(12):2116-23. PubMed ID: 16294265
    [Abstract] [Full Text] [Related]

  • 13. Osteoprotegerin ligand regulates osteoclast adherence to the bone surface in mouse calvaria.
    O'Brien EA, Williams JH, Marshall MJ.
    Biochem Biophys Res Commun; 2000 Aug 02; 274(2):281-90. PubMed ID: 10913332
    [Abstract] [Full Text] [Related]

  • 14. Different levels of the neuronal nitric oxide synthase isoform modulate the rate of osteoclastic differentiation of TIB-71 and CRL-2278 RAW 264.7 murine cell clones.
    Nicolin V, Ponti C, Narducci P, Grill V, Bortul R, Zweyer M, Vaccarezza M, Zauli G.
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Oct 02; 286(2):945-54. PubMed ID: 16142787
    [Abstract] [Full Text] [Related]

  • 15. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.
    J Bone Miner Res; 2005 Sep 02; 20(9):1659-68. PubMed ID: 16059637
    [Abstract] [Full Text] [Related]

  • 16. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis.
    Hirayama T, Danks L, Sabokbar A, Athanasou NA.
    Rheumatology (Oxford); 2002 Nov 02; 41(11):1232-9. PubMed ID: 12421995
    [Abstract] [Full Text] [Related]

  • 17. In vitro osteoclastogenesis on textile chitosan scaffold.
    Heinemann C, Heinemann S, Bernhardt A, Lode A, Worch H, Hanke T.
    Eur Cell Mater; 2010 Feb 26; 19():96-106. PubMed ID: 20186669
    [Abstract] [Full Text] [Related]

  • 18. Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts.
    Kanno S, Hirano S, Kayama F.
    Toxicology; 2004 Oct 15; 203(1-3):211-20. PubMed ID: 15363596
    [Abstract] [Full Text] [Related]

  • 19. Formation of osteoclasts on calcium phosphate bone cements and polystyrene depends on monocyte isolation conditions.
    Bernhardt A, Schumacher M, Gelinsky M.
    Tissue Eng Part C Methods; 2015 Feb 15; 21(2):160-70. PubMed ID: 24919531
    [Abstract] [Full Text] [Related]

  • 20. Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP-1 and RANTES.
    Kim MS, Magno CL, Day CJ, Morrison NA.
    J Cell Biochem; 2006 Feb 15; 97(3):512-8. PubMed ID: 16211583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.